Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-04-11 | SenzaGen | NOTICE OF ANNUAL GENERAL MEETING OF SENZAGEN AB (Publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-11 | SenzaGen | Kallelse till årsstämma i SenzaGen AB (Publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-25 | SenzaGen | SenzaGen’s chemical industry orders continue to increase | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-25 | SenzaGen | SenzaGens orderingång från kemikalieindustrin fortsätter att öka | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-22 | SenzaGen | SenzaGen publicerar årsredovisningen för 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-03-22 | SenzaGen | SenzaGen’s Annual Report 2023 published | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-03-06 | SenzaGen | SenzaGen presenterar och anordnar paneldebatt på SOT Annual Meeting & ToxExpo 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-06 | SenzaGen | SenzaGen presents and hosts a panel discussion at the SOT Annual Meeting & ToxExpo 2024 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-20 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med SenzaGen - Carnegie Investment Bank - 20 feb 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-02-15 | Penser Access by Carnegie | Penser Access by Carnegie: SenzaGen - Bra position in i 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-02-15 | Redeye | Redeye: SenzaGen H2 - Continued growth and aligned with our expectations | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-14 | SenzaGen | SenzaGen’s 2023 Year-End Report: Company approaching breakeven with SEK 50 million in sales | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-14 | SenzaGen | SenzaGens bokslutskommuniké 2023: Bolaget närmar sig break-even med en omsättning på 50 miljoner kronor | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-07 | SenzaGen | Invitation to the presentation of SenzaGen’s year-end report 2023 on Feb 14 at 10.00 CET | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-07 | SenzaGen | Inbjudan till presentation av SenzaGens bokslutskommuniké 2023 den 14 februari kl 10.00 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-10 | SenzaGen | SenzaGen får uppföljningsorder värd 1,5 MSEK för GARD®skin-tester till kemikalieindustrin | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-10 | SenzaGen | SenzaGen receives a follow-up order worth 1.5 million SEK for GARD®skin for the chemical industry | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-18 | SenzaGen | SenzaGen får order på 1,7 MSEK från ny världsledande kund inom biotech-industrin | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-18 | SenzaGen | SenzaGen secures SEK 1.7m order from a new global biotech industry leader | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-29 | SenzaGen | SenzaGen byter likviditetsgarant till Carnegie | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-29 | SenzaGen | SenzaGen changes its market maker to Carnegie | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-08 | SenzaGen | SenzaGen är ett av Sveriges snabbast växande teknikbolag | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-08 | SenzaGen | SenzaGen ranked one of Sweden's fastest-growing technology companies | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-26 | SenzaGen | SenzaGen secures strategically important order from new customer, a world leader in fast-moving consumer goods (FMCG) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-26 | SenzaGen | SenzaGen säkrar strategiskt viktig order från ny världsledande kund inom FMCG (dagligvaror) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-25 | SenzaGen | Continued growth and expanded customer base for SenzaGen during the third quarter | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-25 | SenzaGen | Fortsatt tillväxt och breddad kundbas för SenzaGen under tredje kvartalet | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-18 | SenzaGen | SenzaGen presenterar på BioStock Life Science Summit den 26 oktober | Pressreleaser | Visa Stäng |
|
||||
2023-09-28 | SenzaGen | SenzaGen continues to collaborate with RIFM in non-animal photosensitization and fragrance safety – receives a new grant worth SEK 1.6m | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-28 | SenzaGen | SenzaGen fortsätter att samarbeta med RIFM inom djurfri fotosensibilisering och doftsäkerhet – får nytt uppdrag värt 1,6 MSEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Penser Access | Penser Access: På väg mot kassaflödesneutralitet - SenzaGen | Pressreleaser | Visa Stäng |
|
||||
2023-08-25 | Redeye | Redeye: SenzaGen H1 2023 - Increased customer base | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-24 | SenzaGen | SenzaGens halvårsrapport 2023: Fortsatt tillväxt, förbättrad bruttomarginal och minskad förlust | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-24 | SenzaGen | SenzaGen’s 2023 Half-Year Report: Continued growth, improved gross margin and lower loss | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-07-07 | SenzaGen | SenzaGen stärker marknadsnärvaron genom utökade distributionskanaler | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-07 | SenzaGen | SenzaGen strengthens its market presence with expanded distribution channels | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-12 | Penser Access | Penser Access: Intervju med SenzaGen - Erik Penser Bank - 11 maj 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-05-11 | SenzaGen | SenzaGen utser likviditetsgarant | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-11 | SenzaGen | SenzaGen appoints market maker | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-04 | SenzaGen | Kommuniké från årsstämma i SenzaGen AB den 4 maj 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-04 | SenzaGen | Report from AGM of SenzaGen AB on 4 May 2023 | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Report from AGM of SenzaGen AB on 4 May 2023The Annual General Meeting (AGM) of SenzaGen held on today’s date, 4 May 2023 in Lund, resolved to pass all proposals presented by the board and shareholders. Adoption of income statement and balance sheet Appropriation of earnings Discharge from liability Election of directors and auditors and their fees The AGM resolved to set directors’ fees at SEK 1,200,000 in total, with SEK 200,000 for each non-employee director and SEK 400,000 for the board chairman. Auditor’s fees shall be payable on the basis of approved invoices. Remuneration policies for senior executives Authorization for the board to resolve to issue new shares The purpose of the authorization is to enable the board to raise working capital for the Company, and/or bring in new owners of strategic significance to the Company, and/or acquire other companies or businesses. Directed issue of a maximum of 1,015,000 stock options With the shareholders’ preemptive rights waived, employees of the Company and the Group shall be entitled to subscribe for the stock options as follows:
The subscriber is entitled to subscribe for stock options free of charge. Given that the stock options are issued free of charge, the Company estimates that fringe benefits and social security expenses will be incurred for the participant and the Company as a result of the option plan. The total expenses, including other expenses in the form of fees to external advisers and expenses for the administration of the plan, are estimated at around SEK 100,000 over the program’s term and the cost of social security expenses is estimated at SEK 631,991. The market value of the option shall be calculated using the Black-Scholes pricing model subject to barrier conditions to calculate the Company’s social security expenses. The valuation of the options shall be performed by an independent valuation institute or auditing firm. Each stock option entitles the holder to subscribe for one new share in the Company in exchange for cash payment, provided that the barrier conditions have been met, during the period from 1 June 2026 to 30 September 2026 or the earlier date set out in the option rules. Payment for shares subscribed for by exercising stock options shall be made in cash at an exercise price of 100% of the average of the listed volume-weighted price paid for each trading day as per Nasdaq First North Growth Markets’ official price list for shares in the Company during the period from 19 April 2023 to 3 May 2023. For each individual participant in the stock option plan, 80 percent of all allotted stock options are subject to barrier conditions, and these 80 percent of the stock options can only be exercised to subscribe for shares once the volume-weighted price paid measured per trading day as per the Nasdaq First North Growth Market’s official price list for shares is higher than the respective barrier level. The barrier levels are calculated as a percentage of the average volume-weighted price as per the Nasdaq First North Growth Market’s official price list for shares in the Company during the period from 19 April 2023 to 3 May 2023 ( “the Barrier Price” ). The barrier levels shall consist of two barriers, with the first barrier accounting for 25 percent ( “Barrier 1” ) and the second barrier accounting for 55 percent ( “Barrier 2” ) of all the stock options allotted to participants, in accordance with what is set out below.
New shares subscribed for by exercising stock options entitle the holder to dividends for the first time on the dividend record date most immediately following the date the new share issue was registered with the Swedish Companies Registration Office and Euroclear Sweden AB. For detailed rules regarding the resolution passed at the AGM, please see the AGM notice available at the Company’s website, www.senzagen.com . |
||||
2023-05-04 | Penser Access | Penser Access: Giftfri tillväxt - SenzaGen | Pressreleaser | Visa Stäng |
|
||||
2023-04-26 | SenzaGen | Uthållig och stark försäljningsutveckling för SenzaGen under årets första kvartal | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-26 | SenzaGen | Consistent and strong sales growth for SenzaGen in Q1 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|